Physician profile
Mark G Bearman
NPI 1932102480
$5,320.06
in general payments reported to CMS, 2019-2025
22 companies · $721 in 2025
The $721 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $316 · 2021: $530 · 2022: $917 · 2023: $809 · 2024: $1,040 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,869.02 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| New World Medical,INC. | $635.71 | 2022-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Bausch & Lomb Americas INC. | $403.49 | 2022-2025 | Envista Envy Iol, Miebo, Vyzulta |
| Glaukos Corporation | $335.65 | 2019-2024 | Idose, Ce-Marked Kxla System |
| Ocular Therapeutix, INC. | $267.02 | 2019-2025 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $172.03 | 2019-2021 | |
| Allergan, INC. | $99.68 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $67.56 | 2019-2024 | |
| Abbvie INC. | $62.38 | 2024 | |
| Rxsight INC | $60.95 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Carl Zeiss Meditec USA, INC. | $55.67 | 2022 | |
| Novartis Pharmaceuticals Corporation | $49.80 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $47.28 | 2019-2021 | |
| Coopervision INC. | $45.42 | 2019 | |
| Ethicon US, LLC | $24.29 | 2024 | Stratafix, Harmonic |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akorn, INC. | $21.58 | 2020 | |
| Oyster Point Pharma, INC. | $20.39 | 2022 | |
| Thea Pharma INC. | $20.27 | 2024 | Iyuzeh |
| Horizon Therapeutics Plc | $16.51 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $15.71 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $15.44 | 2022 | |
| Biotissue Holdings INC. | $14.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bearman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.